Long-Term Recovery Outcomes: Fecal Transplant Versus Antibiotics for C. difficile
Part of Infections clinical trials.
This study follows patients who were treated for a C. difficile infection (a serious gut bacteria infection) at Umeå University Hospital to compare how well they recover long-term with either a fecal microbiota transplant (FMT—transferring healthy gut bacteria from a donor) or antibiotic treatment alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were at least 18 years old when diagnosed with C. difficile infection between February 2016 and December 2024
- Your C. difficile infection was confirmed by lab testing (not just clinical suspicion)
- You received treatment for C. difficile at Umeå University Hospital
- You meet the official ESCMID definition of a C. difficile case (standard medical criteria)
- You did not have another gut infection (virus or bacteria) that better explains your symptoms at the time
- You are willing to participate and provide follow-up information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This trial compares three treatments for Clostridioides difficile infection (a severe diarrhea caused by bacteria) to see which works best and prevents it from coming back. It tests a fecal microbiota transplant (FMT, transferring healthy donor stool), fidaxomicin, and vancomycin, all given by mouth or tube.
This study looks at “rescue” fecal microbiota transplantation (FMT), which replaces gut microbes using stool from a screened donor, for intestinal infections that have not improved with standard care. It may help patients whose infection keeps coming back or doesn’t respond to treatment.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This study tests if a freeze-dried fecal transplant (FMT) can help people with difficult-to-treat diarrhea caused by IBS-D or recurring C. diff infections. It's a way to restore healthy gut bacteria and may reduce symptoms.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.